This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Study of Efficacy and Safety of CTL019 in Adult DL...
Clinical trial

Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients (JULIET)

Read time: 2 mins
Last updated:29th Jul 2015
Identifier: NCT02445248

This is a multi-center, phase II study to determine the efficacy and safety of CTL019 in adult patients with relapsed or refractory DLBCL.


Study Type: Interventional
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Phase II, Single Arm, Multicenter Trial to Determine the Efficacy and Safety of CTL019 in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Estimated Enrollment: 130
Actual Study Start Date: July 29, 2015
Estimated Study Completion Date: January 1, 2024
Estimated Primary Completion Date: January 1, 2024 (Final data collection date for primary outcome measure)

Arms:
- Experimental:
CTL019

Category Value
Date last updated at source 2017-11-07
Study type(s) Interventional
Expected enrolment 130
Study start date 2015-07-29
Estimated primary completion date 2024-01-01

View full details